FDA Inspection 1343468 — BGS US LLC
The FDA completed an inspection of BGS US LLC on Oct 21, 2026 in Imperial, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 21, 2026
- Fiscal Year
- 2027
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Imperial, PA (United States)